ISHLT Presents Xenotransplantation Webinar May 25
The use of animal organs for transplantation into human recipients has continued since the mid-20th century in an effort to provide a larger and more readily accessible pool of donor organs to patients in desperate need. Early clinical trials from the 1960s to 1980s revealed serious setbacks and obstacles.
“Xenotransplantation has received increased attention in the media recently,” Dr. Urschel said. “This recent return to clinical application is the result of several decades of relentless research and animal testing that has advanced our understanding of immunological and hemostatic barriers, as well as the application of newly developed breakthrough techniques for the manipulation genetics and metabolism.
“In this ISHLTv webinar, pioneers and global experts in this field will give us insight into the barriers faced and attempts to overcome them, but also current concerns and limitations,” Dr. Urschel continued. “We will hear about the amazing discoveries and interventions at the molecular level that paved the way to bring this approach back to clinical reality, but also the practical and ethical concerns on every clinician’s mind, including lessons learned from clinical trials. past.”
The webinar will explore immunological and metabolic barriers and how to overcome them, considerations around infectious disease transmission between species, how to prevent them, and additional ethical concerns at the patient and population level. A round table including all the speakers and additional speakers will allow questions to be posed to the experts.
Anna MeyerMD Simon UrschelMD, PhD
Leipzig Heart Center University of Alberta
leipzigGermany Edmonton, Alta. Canada
Of mice and men: genetic engineering to defeat
Richard PiersonMDMassachusetts General Hospital, Boston, MAUNITED STATES
Is the solution the solution? Organ preservation and surgical aspects of xenotransplantation
Paul BrennerMDUniversity of Munich, Munich, Germany
Perioperative management of a xenograft
Muhammad M Mohiuddin, MDRush-Presbyterian – St. Luke’s Medical Center, Baltimore, MDUNITED STATES
Are we smarter after the pandemic? Risk and prevention of interspecific infectious transmission in xenotransplantation
Jay FishmanMDMassachusetts General Hospital, Boston, MAUNITED STATES
38 years after baby Fae: ethical considerations around xenotransplantation and associated genetic manipulation
Richard ChinnockMD, MHCM, Loma Linda University Children’s Hospital, Loma Linda, CaliforniaUNITED STATES
Webinar registration is free for ISHLT members and $22 for everyone else. All registrants will receive on-demand access to the webinar to watch anytime after the live presentation. Register on ishlt.org/ishltv.
The International Society for Heart and Lung Transplantation is a non-profit, multidisciplinary professional organization dedicated to improving care for patients with advanced heart or lung disease through transplantation, mechanical support and innovative therapies. With members in more than 50 countries, ISHLT is the world’s largest organization dedicated to research, education and advocacy for end-stage heart and lung disease. ISHLT members represent more than 15 different professional disciplines. For more information, visit www.ishlt.org.
SOURCE The International Society of Heart and Lung Transplantation